P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K140.7 KBPanbela Therapeutics, Inc.Feb 18, 4:32 PM ET·0001437749-25-004225
- 8-K160.7 KBPanbela Therapeutics, Inc.Feb 4, 4:02 PM ET·0001437749-25-002718
- 8-K146.1 KBPanbela Therapeutics, Inc.Jan 22, 4:02 PM ET·0001437749-25-001557
- 8-K327.9 KBPanbela Therapeutics, Inc.Nov 18, 4:16 PM ET·0001437749-24-035616
- 10-Q4.1 MBPanbela Therapeutics, Inc.Nov 14, 4:16 PM ET·0001437749-24-035315
- 8-K411.7 KBPanbela Therapeutics, Inc.Nov 14, 4:12 PM ET·0001437749-24-035305
- SC 13D67.9 KBPanbela Therapeutics, Inc.Oct 29, 7:40 PM ET·0001193125-24-246727
- 8-K471.6 KBPanbela Therapeutics, Inc.Oct 28, 5:16 PM ET·0001437749-24-032318
- 8-K189.5 KBPanbela Therapeutics, Inc.Sep 27, 4:34 PM ET·0001437749-24-030192
- S-1/A10.0 MBPanbela Therapeutics, Inc.Aug 16, 5:25 PM ET·0001437749-24-027110
Insiders
10- Cullen Michael T.Director
- Donovan DanielDirector
- Fratamico ArthurDirector
- Gagnon SuzanneDirector, Chief Medical Officer
- GILBERTSON RYAN RANDALL10% Owner
- GOLDMAN SACHS & CO. LLC10% Owner
- GOLDMAN SACHS GROUP INC10% Owner
- Horvath SusanV.P. of Finance & CFO
- Jacob Jeffrey E.Director
- KAYSEN DAVID BPresident and CEO
Tickers
No tickers on record
Addresses
business
712 VISTA BLVD #305
WACONIA, MN, 55387
mailing
712 VISTA BLVD #305
WACONIA, MN, 55387
Former Names
- Sun BioPharma, Inc.2020-12-02
- Cimarron Medical, Inc.2015-09-04
- CIMARRON SOFTWARE INC2015-05-26